We’ve watched with interest as the pendulum has swung back and forth over the years on the possible efficacy of agents that block Vascular Endothelial Growth Factor (VEGF), a molecule that mediates angiogenesis (the vascular growth that occurs in tumors). Bevacizumab, a monoclonal antibody to VEGF, is known as Avastin and is manufactured by Genentech. [...]